Status:
UNKNOWN
Prevalence and Pathophysiology of Systemic Arterial Pressure Abnormalities in Childhood Sickle Cell Disease
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
6-18 years
Brief Summary
It is usually found that the blood pressure of adults with sickle cell disease is lower than in non-sickle cell patients. On the other hand, three recent prospective studies in children with sickle ce...
Detailed Description
Main objective (200 children): To evaluate the prevalence of elevated blood pressure (former pre-hypertension) and hypertension (including masked hypertension) in children with sickle cell disease. Se...
Eligibility Criteria
Inclusion
- child (age \<18 years);
- sub-Saharan or Caribbean origin;
- major sickle cell disease (SS, SC and Sbeta-thalassemia);
- height ≥ 120 cm; absence of treated hypertension or antihypertensive treatment;
- parents informed and not opposed to participation in research
Exclusion
- \-
Key Trial Info
Start Date :
June 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2023
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04911049
Start Date
June 1 2021
End Date
June 1 2023
Last Update
October 18 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Robert Debre Hospital
Paris, France, 75019